title: The expression of interleukin-8 and interleukin-8 receptors in endometrial carcinoma.
abstract: Interleukin-8 (IL-8) is a pro-inflammatory cytokine which exerts its effects via binding to 2 receptors, CXCR1 and CXCR2 and is known to promote angiogenesis, mitogenesis and motogenesis in cancer. IL-8 is over expressed in endometrial carcinoma, but the expression of CXCR1 and CXCR2 in endometrial carcinoma has not been previously investigated. The aim of this study was to determine the expression of IL-8 receptors in endometrial carcinoma. The expression of CXCR1 and CXCR2 was studied in endometrial carcinomas and normal endometrium by immunohistochemistry in 101 tumours. IL-8 and IL-8 receptor expression was also studied by Real-time quantitative PCR (RT-qPCR) in 17 tumours in comparison to normal endometrium. The expression profile was correlated to the clinico-pathological features of the tumours. Immunohistochemistry showed CXCR1 and CXCR2 were expressed in all cases of endometrial carcinoma, with CXCR1 showing stronger expression. There was a statistically significant correlation between CXCR2 staining intensity and tumour grade (P=0.012) and disease free survival (P=0.015) independently. On RT-qPCR, 14/17, 15/17 and 16/17 tumours showed significant increase in IL-8, CXCR1 and CXCR2 expression levels in comparison to normal endometrium, with median fold increase of 42-fold, 51-fold and 27-fold, respectively. This is the first report of the expression of IL-8 receptors in endometrial carcinoma and the results show an association between IL-8 and IL-8 receptors and the pathogenesis of endometrial carcinoma, and represent potential prognostic biomarkers and therapeutic targets.
authors.affiliation: Medicine, Imperial College London, United Kingdom.
authors.forename: Lauren
authors.initials: L
authors.lastname: Ewington
authors.forename: Alexandra
authors.initials: A
authors.lastname: Taylor
authors.forename: Ruethairat
authors.initials: R
authors.lastname: Sriraksa
authors.forename: Yoshiya
authors.initials: Y
authors.lastname: Horimoto
authors.forename: Eric W-F
authors.initials: EW
authors.lastname: Lam
authors.forename: Mona A
authors.initials: MA
authors.lastname: El-Bahrawy
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016889:Endometrial Neoplasms / Q000235:genetics* / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D016209:Interleukin-8 / Q000235:genetics* / Q000378:metabolism; D008875:Middle Aged; D060888:Real-Time Polymerase Chain Reaction; D023062:Receptors, Interleukin-8A / Q000235:genetics* / Q000378:metabolism; D023063:Receptors, Interleukin-8B / Q000235:genetics* / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: C508606:CXCL8 protein, human; D016209:Interleukin-8; D023062:Receptors, Interleukin-8A; D023063:Receptors, Interleukin-8B